Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 8/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.53 |
| ▸ | HPGD | P15428 | 5/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | MAPT | P10636 | 4/20 | 0.53 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.46 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.44 |
| ▸ | ACACA | Q13085 | 1/20 | 0.43 |
| ▸ | CTRC | Q99895 | 1/20 | 0.42 |
| ▸ | DHODH | Q02127 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17598585 | 1.00 | MEN1 (0.53) | MEN1KMT2AHPGDALDH1A1MAPT | |
| SCHEMBL17829305 | 0.97 | MEN1 (0.56) | MEN1KMT2AHPGDALDH1A1MAPT | |
| SCHEMBL17829314 | 0.97 | MEN1 (0.56) | MEN1KMT2AHPGDALDH1A1MAPT | |
| SCHEMBL17598663 | 0.95 | MEN1 (0.51) | MEN1KMT2AHPGDALDH1A1MAPT | |
| SCHEMBL17598581 | 0.95 | MEN1 (0.51) | MEN1KMT2AHPGDALDH1A1MAPT | |
| SCHEMBL21131530 | 0.94 | MEN1 (0.53) | MEN1KMT2AHPGDALDH1A1MAPT | |
| SCHEMBL17829284 | 0.92 | MEN1 (0.54) | MEN1KMT2AHPGDALDH1A1MAPT | |
| SCHEMBL17829285 | 0.92 | MEN1 (0.54) | MEN1KMT2AHPGDALDH1A1MAPT | |
| SCHEMBL21131687 | 0.92 | MEN1 (0.62) | MEN1KMT2AHPGDALDH1A1MAPT | |
| SCHEMBL21131529 | 0.92 | MEN1 (0.62) | MEN1KMT2AHPGDALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11211563-B2 | Organic light emitting device | LG CHEM, LTD. (KR) | 2021-12-28 | — | — | US | disclosed |
| EP-3498804-B1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEMICAL LTD (KR) | 2020-06-03 | — | — | EP | disclosed |
| US-20190198766-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2019-06-27 | — | — | US | disclosed |
| EP-3498804-A1 | ORGANIC LIGHT EMITTING DEVICE | LG Chem, Ltd. (KR) | 2019-06-19 | — | — | EP | disclosed |
| US-20160172598-A1 | HETERO RING COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2016-06-16 | — | — | US | disclosed |
| US-20160172598-A1 | HETERO RING COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2016-06-16 | — | — | US | disclosed |
| EP-2995616-A1 | HETERO RING COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | LG Chem, Ltd. (KR) | 2016-03-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160172598-A1 | HETERO RING COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | CRY1, CRY2, PER2 | MEN1 2678/4885KMT2A 536/4885HPGD 3263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.